Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Frey

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Clinical and Vaccine Immunology : CVI|May 18, 2012
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccinesChristine M Hughes, Frances K Newman, Whitni B Davidson, et al.
Vaccine|November 13, 2018
Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant womenFlor M Munoz, Lisa A Jackson, Geeta K Swamy, et al.
Vaccine|January 11, 2025
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®Sharon E Frey, Rebecca Brady, Lisa Jackson, et al.
The Journal of Infectious Diseases|March 6, 2021
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity ResponsesSharon E Frey, Jack T Stapleton, Zuhair K Ballas, et al.
The Journal of Infectious Diseases|June 16, 2007
Antibody responses to vaccinia membrane proteins after smallpox vaccinationSteven J Lawrence, Kathleen R Lottenbach, Frances K Newman, et al.
Vaccine|July 3, 2018
Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding womenRebecca C Brady, Lisa A Jackson, Sharon E Frey, et al.
The Journal of Infectious Diseases|August 19, 2011
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant womenLisa A Jackson, Shital M Patel, Geeta K Swamy, et al.
The Journal of Infectious Diseases|September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adultsJeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Vaccine|January 24, 2021
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and olderPatricia Winokur, Hana M El Sahly, Mark J Mulligan, et al.
Plos One|March 26, 2013
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansJohn Lok Man Law, Chao Chen, Jason Wong, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Clinical and Vaccine Immunology : CVI|May 18, 2012
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccinesChristine M Hughes, Frances K Newman, Whitni B Davidson, et al.
Vaccine|November 13, 2018
Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant womenFlor M Munoz, Lisa A Jackson, Geeta K Swamy, et al.
Vaccine|January 11, 2025
Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®Sharon E Frey, Rebecca Brady, Lisa Jackson, et al.
The Journal of Infectious Diseases|March 6, 2021
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity ResponsesSharon E Frey, Jack T Stapleton, Zuhair K Ballas, et al.
The Journal of Infectious Diseases|June 16, 2007
Antibody responses to vaccinia membrane proteins after smallpox vaccinationSteven J Lawrence, Kathleen R Lottenbach, Frances K Newman, et al.
Vaccine|July 3, 2018
Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding womenRebecca C Brady, Lisa A Jackson, Sharon E Frey, et al.
The Journal of Infectious Diseases|August 19, 2011
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant womenLisa A Jackson, Shital M Patel, Geeta K Swamy, et al.
The Journal of Infectious Diseases|September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adultsJeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Vaccine|January 24, 2021
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and olderPatricia Winokur, Hana M El Sahly, Mark J Mulligan, et al.
Plos One|March 26, 2013
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humansJohn Lok Man Law, Chao Chen, Jason Wong, et al.
Pageof 12